If you need more lookups,
subscriptions start at $34 USD/month.
Blai Coll Location
Thousand Oaks, CA, US
Blai Coll Work
Chief Medical Officer @ (September 2024 - Present)
VP Endocrine and Metabolism Clinical Development @ (May 2022 - September 2024)
Cardiovascular and Metabolic Platform Lead, Medical Affairs at Amgen @ (June 2020 - May 2022)
US Medical Lead, Repatha @ (November 2018 - June 2020)
Medical Director Global Medical Affairs Cardiovascular @ (September 2017 - November 2018)
Clinical Research Medical Director Amgen Cardiovascular @ (August 2016 - September 2017)
Medical Director @ (January 2013 - July 2016)
Associate Medical Director, Renal Development @ Abbott (November 2010 - January 2013)
Internal Medicine Fellow @ Hospital Sant Joan, Reus (November 2010 - January 2013)
Director @ UDETMA 2008-2010 (February 2008 - October 2010)
Clinical Research Fellow @ Instituto de Salud Carlos III, Hospital Sant Joan (Reus) (May 2004 - February 2008)
Blai Coll Education
Universitat Rovira i Virgili
PhD (Medicine)
2004-2007
Internal Medicine
PhD (Atherosclerosis)
1998-2003
Universitat Autonoma de Barcelona School of Medicine
Medical doctor (Medicine)
1991-1997
Internal Medicine
PhD
Blai Coll Skills
Clinical Development
Clinical Trials
Clinical Research
Corporate Communications
Pharmaceutical Industry
Cardiology
Internal Medicine
Therapeutic Areas
Drug Development
Hospitals
Medicine
Regulatory Affairs
Healthcare
Diabetes
Biotechnology
Life Sciences
Blai Coll Summary
Blai Coll, based in Thousand Oaks, CA, US, is currently a Chief Medical Officer at Structure Therapeutics. Blai Coll brings experience from previous roles at Structure Therapeutics and Amgen. Blai Coll holds a 2004 - 2007 PhD in Medicine @ Universitat Rovira i Virgili. With a robust skill set that includes Clinical Development, Clinical Trials, Clinical Research, Corporate Communications, Pharmaceutical Industry and more. Blai Coll has 2 emails and 2 mobile phone numbers on RocketReach.
Looking for a different Blai Coll?
Find contact details for 700 million professionals.